Gene Editing Maternal opioid treatment after delivery not associated with adverse infant outcomes Posted on March 16, 2023 by Editorial Staff Infants born to mothers prescribed opioids after delivery, mostly after a cesarean, are at no greater risk of harm shortly after birth than infants of mothers not prescribed opioids, finds a large study from Canada published by The BMJ today. Share on FacebookTweetFollow us Editorial Staff Albumedix and Heartseed announce Recombumin® as a critical excipient in the manufacture of Heartseed’s HS-001 investigational cell therapy as its first in-human trial commences AI-based drug interaction prediction technology analyzes the interaction between Paxlovid ingredients